CatalystPit

ARVNARVINAS, INC.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $7.74 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$505.76M
CountryUSA
RECENT INSIDER TRADES
  • 2026-06-24 · Saik Andrew (Chief Financial Officer) · SELL
  • 2026-06-18 · Cacace Angela M (Chief Scientific Officer) · SELL
  • 2026-05-22 · Teel Randy (President and CEO) · SELL
  • 2026-05-13 · Teel Randy (President and CEO) · SELL
  • 2026-05-13 · Loomis David K (VP, Chief Accounting Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders223
Shares held74,410,860
Value$783.08M
Percent of shares outstanding113.80%
As of quarter end2026-06-30
RECENT NEWS
  • Arvinas reports Phase 1 data for ARV-102 in Parkinson's disease
  • Arvinas to present ARV-102 Parkinson’s data at MDS congress
  • ARVN: Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader
  • ARVN: Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  • Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS